Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Christopher Carpenter

    TitleHS CLIN INSTR-HCOMP
    SchoolUCSF School of Medicine
    DepartmentPediatrics
    Address505 Parnassus Avenue
    San Francisco CA 94117
    Phone415-476-5001
    vCardDownload vCard

      Collapse ORNG Applications 
      Collapse Global Health

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Van Aller GS, Graves AP, Elkins PA, Bonnette WG, McDevitt PJ, Zappacosta F, Annan RS, Dean TW, Su DS, Carpenter CL, Mohammad HP, Kruger RG. Structure-Based Design of a Novel SMYD3 Inhibitor that Bridges the SAM-and MEKK2-Binding Pockets. Structure. 2016 May 3; 24(5):774-81. PMID: 27066749.
        View in: PubMed
      2. Carpenter CL, Cuellar TA, Friel MT. Office-Based Post-Axial Polydactyly Excision in Neonates, Infants, and Children. Plast Reconstr Surg. 2016 Feb; 137(2):564-8. PMID: 26818291.
        View in: PubMed
      3. Mohammad HP, Smitheman KN, Kamat CD, Soong D, Federowicz KE, Van Aller GS, Schneck JL, Carson JD, Liu Y, Butticello M, Bonnette WG, Gorman SA, Degenhardt Y, Bai Y, McCabe MT, Pappalardi MB, Kasparec J, Tian X, McNulty KC, Rouse M, McDevitt P, Ho T, Crouthamel M, Hart TK, Concha NO, McHugh CF, Miller WH, Dhanak D, Tummino PJ, Carpenter CL, Johnson NW, Hann CL, Kruger RG. A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC. Cancer Cell. 2015 Jul 13; 28(1):57-69. PMID: 26175415.
        View in: PubMed
      4. Choueiri TK, Figueroa DJ, Fay AP, Signoretti S, Liu Y, Gagnon R, Deen K, Carpenter C, Benson P, Ho TH, Pandite L, de Souza P, Powles T, Motzer RJ. Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial. Clin Cancer Res. 2015 Mar 1; 21(5):1071-7. PMID: 25538263.
        View in: PubMed
      5. Lauriol J, Keith K, Jaffré F, Couvillon A, Saci A, Goonasekera SA, McCarthy JR, Kessinger CW, Wang J, Ke Q, Kang PM, Molkentin JD, Carpenter C, Kontaridis MI. RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis. Sci Signal. 2014 Oct 21; 7(348):ra100. PMID: 25336613; PMCID: PMC4300109.
      6. Choueiri TK, Fay AP, Gagnon R, Lin Y, Bahamon B, Brown V, Rosenberg JE, Hutson TE, Baker-Neblett KL, Carpenter C, Liu Y, Pandite L, Signoretti S. The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma. Clin Cancer Res. 2013 Sep 15; 19(18):5218-26. PMID: 23881929; PMCID: PMC4522695.
      7. Sandhu SK, Schelman WR, Wilding G, Moreno V, Baird RD, Miranda S, Hylands L, Riisnaes R, Forster M, Omlin A, Kreischer N, Thway K, Gevensleben H, Sun L, Loughney J, Chatterjee M, Toniatti C, Carpenter CL, Iannone R, Kaye SB, de Bono JS, Wenham RM. The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial. Lancet Oncol. 2013 Aug; 14(9):882-92. PMID: 23810788.
        View in: PubMed
      8. Saci A, Cantley LC, Carpenter CL. Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. Mol Cell. 2011 Apr 8; 42(1):50-61. PMID: 21474067; PMCID: PMC3750737.
      9. Wilkins A, Carpenter CL. Regulation of RhoBTB2 by the Cul3 ubiquitin ligase complex. Methods Enzymol. 2008; 439:103-9. PMID: 18374159.
        View in: PubMed
      10. Jiang X, Borgesi RA, McKnight NC, Kaur R, Carpenter CL, Balk SP. Activation of nonreceptor tyrosine kinase Bmx/Etk mediated by phosphoinositide 3-kinase, epidermal growth factor receptor, and ErbB3 in prostate cancer cells. J Biol Chem. 2007 Nov 9; 282(45):32689-98. PMID: 17823122.
        View in: PubMed
      11. Perez-Mansilla B, Ha VL, Justin N, Wilkins AJ, Carpenter CL, Thomas GM. The differential regulation of phosphatidylinositol 4-phosphate 5-kinases and phospholipase D1 by ADP-ribosylation factors 1 and 6. Biochim Biophys Acta. 2006 Dec; 1761(12):1429-42. PMID: 17071135.
        View in: PubMed
      12. Saci A, Carpenter CL. RhoA GTPase regulates B cell receptor signaling. Mol Cell. 2005 Jan 21; 17(2):205-14. PMID: 15664190.
        View in: PubMed
      13. Yang SA, Carpenter CL, Abrams CS. Rho and Rho-kinase mediate thrombin-induced phosphatidylinositol 4-phosphate 5-kinase trafficking in platelets. J Biol Chem. 2004 Oct 1; 279(40):42331-6. PMID: 15277528.
        View in: PubMed
      14. Wilkins A, Ping Q, Carpenter CL. RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex. Genes Dev. 2004 Apr 15; 18(8):856-61. PMID: 15107402; PMCID: PMC395845.
      15. Chang JD, Field SJ, Rameh LE, Carpenter CL, Cantley LC. Identification and characterization of a phosphoinositide phosphate kinase homolog. J Biol Chem. 2004 Mar 19; 279(12):11672-9. PMID: 14701839.
        View in: PubMed
      16. Saito K, Tolias KF, Saci A, Koon HB, Humphries LA, Scharenberg A, Rawlings DJ, Kinet JP, Carpenter CL. BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity. Immunity. 2003 Nov; 19(5):669-78. PMID: 14614854.
        View in: PubMed
      17. Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, Bajraszewski N, Vazquez F, Carpenter CL, Kwiatkowski DJ. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest. 2003 Oct; 112(8):1223-33. PMID: 14561707; PMCID: PMC213485.
      18. Kadin ME, Carpenter C. Systemic and primary cutaneous anaplastic large cell lymphomas. Semin Hematol. 2003 Jul; 40(3):244-56. PMID: 12876673.
        View in: PubMed
      19. Barkalow KL, Falet H, Italiano JE, van Vugt A, Carpenter CL, Schreiber AD, Hartwig JH. Role for phosphoinositide 3-kinase in Fc gamma RIIA-induced platelet shape change. Am J Physiol Cell Physiol. 2003 Oct; 285(4):C797-805. PMID: 12788695.
        View in: PubMed
      20. Marks SS, Watson DL, Carpenter CL, Messing RO, Greenberg DA. Comparative effects of chronic exposure to ethanol and calcium channel antagonists on calcium channel antagonist receptors in cultured neural (PC12) cells. J Neurochem. 1989 Jul; 53(1):168-72. PMID: 2470859.
        View in: PubMed
      21. Marks SS, Watson DL, Carpenter CL, Messing RO, Greenberg DA. Calcium channel antagonist receptors in cerebral cortex from alcoholic patients. Brain Res. 1989 Jan 23; 478(1):196-8. PMID: 2538202.
        View in: PubMed
      22. Watson DL, Carpenter CL, Marks SS, Greenberg DA. Striatal calcium channel antagonist receptors in Huntington's disease and Parkinson's disease. Ann Neurol. 1988 Mar; 23(3):303-5. PMID: 2967667.
        View in: PubMed
      23. Carpenter CL, Marks SS, Watson DL, Greenberg DA. Dextromethorphan and dextrorphan as calcium channel antagonists. Brain Res. 1988 Jan 26; 439(1-2):372-5. PMID: 2451974.
        View in: PubMed
      Christopher's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP